In this context, Pohl et al. (2017) found a downregulation of the chemerin mRNA levels in livers of humans suffering from a progressive form of NAFLD compared to humans suffering from steatosis alone. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.